ONO-1301 (C008B-268412)

ONO 1301 is a prostacyclin (PGI2) analog and possesses the activity of inhibiting the synthesis enzyme of thromboxane A2. In the chronic pancreatitis model induced by DBTC, ONO 1301 inhibits pancreatic fibrosis through its direct action and by inducing the production of hepatocyte growth factor (HGF), as well as by suppressing the activity of monocytes. ONO 1301 can also promote the synthesis of HGF and increase the intracellular cAMP level through IP receptor signaling, highlighting its therapeutic potential in fibrotic diseases and inflammation research.

Specifications & Purity: ONO 1301 is a prostacyclin (PGI2) analog and possesses the activity of inhibiting the synthesis enzyme of thromboxane A2. In the chronic pancreatitis model induced by DBTC, ONO 1301 inhibits pancreatic fibrosis through its direct action and by inducing the production of hepatocyte growth factor (HGF), as well as by suppressing the activity of monocytes. ONO 1301 can also promote the synthesis of HGF and increase the intracellular cAMP level through IP receptor signaling, highlighting its therapeutic potential in fibrotic diseases and inflammation research.

Grade: Moligand™

Molecular Weight: 428.48

PubChem CID: 6536812

Isomeric SMILES: C1CC2=C(C=CC=C2OCC(=O)O)C(=C1)CCO/N=C(\C3=CC=CC=C3)/C4=CN=CC=C4

Storage Temperature: Protected from light;Store at -20°C;Argon charged

Shipped in: Ice chest + Ice pads

UPC:

51442437

Weight:

1.09 Ounces

HazmatClass:

Yes

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

O612509-100mg

Country of Origin:

China

CAS:

176391-41-6

Product Size:

100mg

Harmonized Tariff Code:

2931.90.90